US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

IMNN

Imunon (IMNN)

Imunon Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMNN

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IMNN	Imunon Inc
2024/05/20	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/05/16	05 : 16	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:IMNN	Imunon Inc
2024/05/15	21 : 30	GlobeNewswire Inc.	Abstract on Phase 2 Study with IMUNON’s IMNN-001 Plus Bevacizumab Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting	NASDAQ:IMNN	Imunon Inc
2024/05/15	05 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2024/05/13	22 : 00	GlobeNewswire Inc.	IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study	NASDAQ:IMNN	Imunon Inc
2024/05/13	21 : 10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IMNN	Imunon Inc
2024/05/13	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/05/13	21 : 00	GlobeNewswire Inc.	IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:IMNN	Imunon Inc
2024/05/08	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2024/05/08	21 : 00	GlobeNewswire Inc.	IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO	NASDAQ:IMNN	Imunon Inc
2024/05/07	00 : 00	GlobeNewswire Inc.	IMUNON to Hold First Quarter 2024 Financial Results and Business Update Conference Call on Monday, May 13, 2024	NASDAQ:IMNN	Imunon Inc
2024/04/18	21 : 30	GlobeNewswire Inc.	IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101	NASDAQ:IMNN	Imunon Inc
2024/04/11	21 : 00	GlobeNewswire Inc.	IMUNON Reports Compliance with Nasdaq Listing Requirements	NASDAQ:IMNN	Imunon Inc
2024/03/28	21 : 00	GlobeNewswire Inc.	IMUNON Reports 2023 Financial Results and Provides Business Update	NASDAQ:IMNN	Imunon Inc
2024/03/25	21 : 30	GlobeNewswire Inc.	IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses	NASDAQ:IMNN	Imunon Inc
2024/03/22	06 : 00	GlobeNewswire Inc.	IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024	NASDAQ:IMNN	Imunon Inc
2024/03/13	21 : 00	GlobeNewswire Inc.	IMUNON Files IND Application to Begin Human Testing of IMNN-101	NASDAQ:IMNN	Imunon Inc
2024/03/13	06 : 00	GlobeNewswire Inc.	IMUNON Announces Leadership Change	NASDAQ:IMNN	Imunon Inc
2024/02/29	22 : 30	GlobeNewswire Inc.	Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5	NASDAQ:IMNN	Imunon Inc
2024/02/27	22 : 30	GlobeNewswire Inc.	Memorial Sloan Kettering Cancer Center Now Enrolling Patients in Phase 1/2 Clinical Trial of IMUNON’s IMNN-001 in Combination with Bevacizumab in Advanced Ovarian Cancer	NASDAQ:IMNN	Imunon Inc
2024/02/22	22 : 00	GlobeNewswire Inc.	IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine	NASDAQ:IMNN	Imunon Inc
2024/02/10	06 : 09	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:IMNN	Imunon Inc
2023/12/30	06 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2023/12/21	07 : 15	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:IMNN	Imunon Inc
2023/12/12	06 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2023/12/12	06 : 05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:IMNN	Imunon Inc
2023/12/11	22 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IMNN	Imunon Inc
2023/12/11	22 : 30	GlobeNewswire Inc.	IMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:IMNN	Imunon Inc
2023/11/14	23 : 00	GlobeNewswire Inc.	IMUNON’s VP of R&D to Present at the Vaccines Summit-2023	NASDAQ:IMNN	Imunon Inc

Showing the most relevant articles for your search:NASDAQ:IMNN

1 2 3 次へ >>

NLBNPIT1ZFR1 20241220 1.8

NLBNPIT1ZJR3 20240918 5300

NLBNPIT1XK92 20241220 300

Etra Tf 4,2% Lg34 Amort ...

Bettermood Food (QB)

Eu Sure Bond Tf 1,125% G...

Betashares Geared Us Eq ...

NLBNPIT1ZVW8 20240619 5000

CNS Pharmaceuticals

Hsbc Usa Inc Capped Dual...

Billerud Ab (PK)

NLBNPIT1YMV2 20991231 35...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約